0
0
8/21/23 at 4:44pm
Organization
CNBC
Author
Annika Kim Constantino
39 words
0
Comments
Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall.
You are the first to view
https://www.cnbc.com/2023/08/21/covid-vaccine-stocks-jump-as-new-variants-emerge.html
Create an account
or login to join the discussion